Stopain Migraine to hit shelves at Rite Aid, H-E-B
Troy Healthcare is expanding retail distribution of its Stopain Migraine topical pain reliever, which a recent study found to be safe and effective in treating an acute migraine attack.
Troy Healthcare is expanding retail distribution of its Stopain Migraine topical pain reliever, which a recent study found to be safe and effective in treating an acute migraine attack.
David Taylor, Procter & Gamble Co.’s group president of global beauty, grooming and health care, has been chosen to succeed A.G. Lafley as the company’s president and chief executive officer. P&G said late Tuesday that Taylor is slated to take the helm as CEO on Nov.
A new sonic toothbrush from Brush Buddies brings consumers a “fresh-out-of-the-dentist clean feeling at drug store prices,” the company said.
Sandoz has launched budesonide inhalation suspension, an asthma medication, in the U.S. market. The Novartis subsidiary said Tuesday that it will market its budesonide inhalation suspension in 1-mg strength, and it expects 180-day generic drug marketing exclusivity for that dosage.
Teva Pharmaceutical Industries Ltd. plans to buy Allergan’s generic drug business for about $40.5 billion and, with the deal, has withdrawn its proposal to acquire Mylan N.V. for approximately $40 billion. Teva said Monday that Dublin, Ireland-based Allergan will receive $33.
Performance Health LLC has expanded its roster of topical analgesic, rehabilitation and wellness products with Perform Atomic Heat, a new topical formula for warming the body before physical activity and relieving muscle, joint and arthritis pain.
Pharmacy automation provider TCGRx has released the ATP 2, a next-generation automated tablet packaging system.
Lupin Ltd. plans to buy Gavis Pharmaceuticals LLC and Novel Laboratories Inc. in an $880 million deal. Lupin said Thursday that the acquisition will boost its scale in the U.S.
Jeff Rogers has been appointed as president of the Physicians Formula Group at Markwins International Corp. Rogers takes over from Ingrid Jackel, who left the company to join natural beauty care manufacturer Yes To Inc. as chief executive officer.
A group of drug- and health-related companies and organizations have formed the Protecting Access to Pain Relief Coalition (PAPR), which seeks to preserve Americans’ access to and choice of safe, effective pain relief best-suited for their condition.
Chester “Chip” Davis has been named president and chief executive officer of the Generic Pharmaceutical Association (GPhA), taking over from Ralph Neas, who is stepping down.
Qore-24, an antimicrobial hand purifier that kills germs for up to 24 hours, has landed retail distribution at Walgreens. Qore Systems, the maker of Qore-24, said Tuesday that the product began rolling out to 3,700 Walgreens stores nationwide earlier this month.
Pfizer Consumer Healthcare has rolled out Caltrate Bone & Joint Health, described as a triple-action supplement to promote bone health.
Ingrid Jackel is joining natural beauty care manufacturer Yes To Inc. as chief executive officer. Yes To said Monday that Jackel comes to Yes To from Physicians Formula, where she held a variety of positions, including CEO, president and chairwoman.
Galderma Laboratories has received Food and Drug Administration approval for antibiotic-free Epiduo Forte Gel (adapalene and benzoyl peroxide 0.3%/2.5%), a once-daily topical acne treatment. Galderma said Thursday Epiduo Forte Gel is the first combination of 0.3%/2.
Cardinal Health Inc. plans to acquire medication therapy management specialist OutcomesMTM. Financial terms of the transaction weren’t disclosed.